SRSF2 mutation is most frequent in CMML, with reports ranging from 28.4 to 47.2%, whereas mutations in SF3B1 gene are less frequent in CMML (5–10%) (Fig. 3D). This evidence concerns the gene SRSF2 and chronic myelomonocytic leukemia.